Global Scopolamine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 143646
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 121
  • list Pharmaceuticals and Healthcare

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

Scope of the Report:

The global production of scopolamine about 2450 Kg in 2015, the production region is mainly concentrated in Australia witch product 43.63% of global scopolamine. The top three companies are Alkaloids of Australia, Centroflora-cms and Fine Chemicals Corporation, they occupies about 62.37% market shares.

Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption North America is about 30.68%, the Europe consumes about 26.65% market share, China occupies about 9.88% market share, Japan occupies about 10.78% market share.

The worldwide market for Scopolamine is expected to grow at a CAGR of roughly 3.8% over the next five years, will reach 20 million US$ in 2024, from 16 million US$ in 2019, according to a new study.

This report focuses on the Scopolamine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Alkaloids of Australia

Centroflora-cms

Fine Chemicals Corporation

Phytex Australia

Alchem International

Guangzhou Hanfang

Alkaloids Corporation

Luyin

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Scopolamine Butylbromide

Scopolamine Hydrobromide

Scopolamine Base

Market Segment by Applications, can be divided into

Oral

Injection

Patches

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Scopolamine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Scopolamine, with price, sales, revenue and global market share of Scopolamine in 2017 and 2018.

Chapter 3, the Scopolamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Scopolamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Scopolamine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Scopolamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Scopolamine Introduction

1.2 Market Analysis by Type

1.2.1 Scopolamine Butylbromide

1.2.2 Scopolamine Hydrobromide

1.2.3 Scopolamine Base

1.3 Market Analysis by Applications

1.3.1 Oral

1.3.2 Injection

1.3.3 Patches

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Alkaloids of Australia

2.1.1 Business Overview

2.1.2 Scopolamine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Alkaloids of Australia Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Centroflora-cms

2.2.1 Business Overview

2.2.2 Scopolamine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Centroflora-cms Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Fine Chemicals Corporation

2.3.1 Business Overview

2.3.2 Scopolamine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Fine Chemicals Corporation Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Phytex Australia

2.4.1 Business Overview

2.4.2 Scopolamine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Phytex Australia Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Alchem International

2.5.1 Business Overview

2.5.2 Scopolamine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Alchem International Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Guangzhou Hanfang

2.6.1 Business Overview

2.6.2 Scopolamine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Guangzhou Hanfang Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Alkaloids Corporation

2.7.1 Business Overview

2.7.2 Scopolamine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Alkaloids Corporation Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Luyin

2.8.1 Business Overview

2.8.2 Scopolamine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Luyin Scopolamine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Scopolamine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Scopolamine Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Scopolamine Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Scopolamine Manufacturer Market Share in 2018

3.3.2 Top 6 Scopolamine Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Scopolamine Market Analysis by Regions

4.1 Global Scopolamine Sales, Revenue and Market Share by Regions

4.1.1 Global Scopolamine Sales and Market Share by Regions (2014-2019)

4.1.2 Global Scopolamine Revenue and Market Share by Regions (2014-2019)

4.2 North America Scopolamine Sales and Growth Rate (2014-2019)

4.3 Europe Scopolamine Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Scopolamine Sales and Growth Rate (2014-2019)

4.5 South America Scopolamine Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Scopolamine Sales and Growth Rate (2014-2019)

5 North America Scopolamine by Country

5.1 North America Scopolamine Sales, Revenue and Market Share by Country

5.1.1 North America Scopolamine Sales and Market Share by Country (2014-2019)

5.1.2 North America Scopolamine Revenue and Market Share by Country (2014-2019)

5.2 United States Scopolamine Sales and Growth Rate (2014-2019)

5.3 Canada Scopolamine Sales and Growth Rate (2014-2019)

5.4 Mexico Scopolamine Sales and Growth Rate (2014-2019)

6 Europe Scopolamine by Country

6.1 Europe Scopolamine Sales, Revenue and Market Share by Country

6.1.1 Europe Scopolamine Sales and Market Share by Country (2014-2019)

6.1.2 Europe Scopolamine Revenue and Market Share by Country (2014-2019)

6.2 Germany Scopolamine Sales and Growth Rate (2014-2019)

6.3 UK Scopolamine Sales and Growth Rate (2014-2019)

6.4 France Scopolamine Sales and Growth Rate (2014-2019)

6.5 Russia Scopolamine Sales and Growth Rate (2014-2019)

6.6 Italy Scopolamine Sales and Growth Rate (2014-2019)

7 Asia-Pacific Scopolamine by Country

7.1 Asia-Pacific Scopolamine Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Scopolamine Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Scopolamine Revenue and Market Share by Country (2014-2019)

7.2 China Scopolamine Sales and Growth Rate (2014-2019)

7.3 Japan Scopolamine Sales and Growth Rate (2014-2019)

7.4 Korea Scopolamine Sales and Growth Rate (2014-2019)

7.5 India Scopolamine Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Scopolamine Sales and Growth Rate (2014-2019)

8 South America Scopolamine by Country

8.1 South America Scopolamine Sales, Revenue and Market Share by Country

8.1.1 South America Scopolamine Sales and Market Share by Country (2014-2019)

8.1.2 South America Scopolamine Revenue and Market Share by Country (2014-2019)

8.2 Brazil Scopolamine Sales and Growth Rate (2014-2019)

8.3 Argentina Scopolamine Sales and Growth Rate (2014-2019)

8.4 Colombia Scopolamine Sales and Growth Rate (2014-2019)

9 Middle East and Africa Scopolamine by Countries

9.1 Middle East and Africa Scopolamine Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Scopolamine Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Scopolamine Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Scopolamine Sales and Growth Rate (2014-2019)

9.3 Turkey Scopolamine Sales and Growth Rate (2014-2019)

9.4 Egypt Scopolamine Sales and Growth Rate (2014-2019)

9.5 Nigeria Scopolamine Sales and Growth Rate (2014-2019)

9.6 South Africa Scopolamine Sales and Growth Rate (2014-2019)

10 Global Scopolamine Market Segment by Type

10.1 Global Scopolamine Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Scopolamine Sales and Market Share by Type (2014-2019)

10.1.2 Global Scopolamine Revenue and Market Share by Type (2014-2019)

10.2 Scopolamine Butylbromide Sales Growth and Price

10.2.1 Global Scopolamine Butylbromide Sales Growth (2014-2019)

10.2.2 Global Scopolamine Butylbromide Price (2014-2019)

10.3 Scopolamine Hydrobromide Sales Growth and Price

10.3.1 Global Scopolamine Hydrobromide Sales Growth (2014-2019)

10.3.2 Global Scopolamine Hydrobromide Price (2014-2019)

10.4 Scopolamine Base Sales Growth and Price

10.4.1 Global Scopolamine Base Sales Growth (2014-2019)

10.4.2 Global Scopolamine Base Price (2014-2019)

11 Global Scopolamine Market Segment by Application

11.1 Global Scopolamine Sales Market Share by Application (2014-2019)

11.2 Oral Sales Growth (2014-2019)

11.3 Injection Sales Growth (2014-2019)

11.4 Patches Sales Growth (2014-2019)

12 Scopolamine Market Forecast (2019-2024)

12.1 Global Scopolamine Sales, Revenue and Growth Rate (2019-2024)

12.2 Scopolamine Market Forecast by Regions (2019-2024)

12.2.1 North America Scopolamine Market Forecast (2019-2024)

12.2.2 Europe Scopolamine Market Forecast (2019-2024)

12.2.3 Asia-Pacific Scopolamine Market Forecast (2019-2024)

12.2.4 South America Scopolamine Market Forecast (2019-2024)

12.2.5 Middle East and Africa Scopolamine Market Forecast (2019-2024)

12.3 Scopolamine Market Forecast by Type (2019-2024)

12.3.1 Global Scopolamine Sales Forecast by Type (2019-2024)

12.3.2 Global Scopolamine Market Share Forecast by Type (2019-2024)

12.4 Scopolamine Market Forecast by Application (2019-2024)

12.4.1 Global Scopolamine Sales Forecast by Application (2019-2024)

12.4.2 Global Scopolamine Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Scopolamine Picture

Table Product Specifications of Scopolamine

Figure Global Sales Market Share of Scopolamine by Types in 2018

Table Scopolamine Types

Please fill the form below, to recieve the report sample


+1